Joint Supplement Safer Than NSAID Diclofenac For Osteoarthritis Pain – Study
This article was originally published in The Rose Sheet
Executive Summary
Wobenzym, an oral enzyme combination supplement could serve as an alternative to Rx NSAID diclofenac, as it is as effective but associated with less treatment-emergent adverse events, finds a Journal of Pain Research study.
You may also be interested in...
Cardiovascular Warning Boosts Profile For OTC NSAID Label Changes
FDA more commonly requires similar changes for prescription drug labels based on emerging science on potential risks, but for non-aspirin NSAID label changes CDER also will contact OTC firms and advise them of changes needed to cardiovascular risk warnings on their product labels. “It doesn’t happen on quite the scale that we’re dealing with here and with the nature of these products,” says attorney Frederick Stearns.
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value of $2.85bn to reduce debt and streamline its business to three segments, including scents.
MoCRA Implementation In US Election Year: Q&A With Attorney Wade Ackerman
Wade Ackerman, partner at Covington & Burling who served previously as senior FDA counsel to US Senate Health Education, Labor & Pensions (HELP) Committee leadership, discusses expectations for FDA activity under modernized cosmetics regulations in 2024.